Alt Pep Appoints Soon Hyouk Lee To Newly Created Position of Chief Business Officer
12/13/23, 1:12 PM
Location
seattleIndustry
biotechnology
Position
chief business officer
AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, today announced that Soon Hyouk Lee has assumed the position of Chief Business Officer of AltPep. In this role, Soon will lead AltPep’s corporate and business development.
Company Info
Location
100 ne northlake way, suite 300
seattle, washington, united states
Additional Info
AltPep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers – toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach.
Our lead program aims to identify Alzheimer’s Disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.